Navitus Earns Sixth PQA Award for High Achievement in Medication Quality Measures
- May 17, 2022
- PBM Model
The 2022 Laura Cranston Excellence in Quality Award recognizes Medicare Advantage Drug Plans (MAPD) and Prescription Drug Plans (PDP) for achieving at least a 4.5-star Part D summary rating and a 5-star rating on all five PQA measures used in the 2022 CMS Star Ratings program. The five PQA measures include Medication Adherence for Diabetes Medications, Medication Adherence for Hypertension (RAS antagonists); Medication Adherence for Cholesterol (Statins); Medication Therapy Management (MTM) Program Completion Rate for Comprehensive Medication Review (CMR); and Statin Use in Persons with Diabetes.
For 2022, Navitus MedicareRx received a 5 out of 5 summary rating, making it Navitus’ sixth year to rank higher than any other PBM-sponsored Medicare PDP Employer Group Waiver Plan. Navitus is one of only twelve healthcare organizations nationwide to receive PQA’s Excellence in Quality Award for PDPs this year. Navitus’ PDP program is managed by Navitus and underwritten by Dean Health Insurance.
“The safe and effective use of medications is a high priority for care providers and the Medicare Part D program,” PQA Chief Executive Officer Micah Cost, PharmD, MS, said. “PQA is proud to recognize 25 plans this year. These awards are a tangible recognition of their commitment to excellence and dedication to providing high-quality care for their Medicare members.”
“Taking medications as prescribed is critical for improving member health outcomes and preventing unnecessary costs. Unfortunately, there are many barriers to adherence, so we are dedicated to improving clinical outcomes through reducing costs, providing personalized support and education to help address these barriers,” said Brent Eberle, senior vice president and chief pharmacy officer at Navitus. “Receiving this award further recognizes Navitus’ commitment to ensuring members receive best-in-class clinical support and customer service.”
The PQA awards are issued annually based on the published CMS Medicare Part D Star Ratings. The awards recognize the nation’s highest achieving prescription drug plans for performance on PQA quality measures of medication safety and appropriate use. The awards reflect PQA’s mission and the vision that co-founder and former CEO Laura Cranston had for building an organization that protects patients and promotes optimal medication outcomes. In 2022, only 2.9% of the 850 Medicare Part D plan contracts qualified for an award.
Navitus Health Solutions, owned by SSM Health and Costco Wholesale Corporation, is a disruptive industry alternative to traditional pharmacy benefit manager (PBM) models. As such, Navitus is committed to taking the unnecessary costs out of pharmacy benefits to make prescriptions more affordable for nearly 1,000 plan sponsors (i.e., employers, health plans, unions, governments, etc.) and their 8.5 million members. By combining a unique pass-through approach that returns 100% of rebates and discounts received, focusing on lowest-net-cost medications and comprehensive clinical care programs, Navitus helps reduce costs and improve member health. To learn more about Navitus, call 877.571.7500 or visit www.navitus.com. Follow Navitus on Twitter and LinkedIn to stay up-to-date on all the latest pharmacy benefit news, information and expert analysis.
For media inquiries, contact Navitus@AllisonPR.com.